Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Clinical trial NCT01675154 · TERMINATED
Trial details
- NCT number
- NCT01675154
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2020-06-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.